[Federal Register Volume 65, Number 119 (Tuesday, June 20, 2000)]
[Notices]
[Page 38293]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-15428]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Nonprescription Drugs Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Nonprescription Drugs Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on July 12, 2000, 1 p.m. to 
5:30 p.m.
    Location: Holiday Inn, Versailles Ballrooms, 8120 Wisconsin Ave., 
Bethesda, MD.
    Contact Person: Sandra L. Titus, Center for Drug Evaluation and 
Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-7001, or e-mail: [email protected], or 
FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 
in the Washington, DC area), code 12541. Please call the Information 
Line for up-to-date information on this meeting.
    Agenda: The committee will discuss the remarketing and labeling of 
the Today Vaginal Contraceptive Sponge, new drug application 
(NDA) 18-683, Allendale Pharmaceuticals. This product was approved by 
FDA in 1983, but has not been marketed since January 1995.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by July 6, 2000. 
Oral presentations from the public will be scheduled between 
approximately 1:15 p.m. and 2:15 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before July 6, 2000, and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: June 9, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-15428 Filed 6-19-00; 8:45 am]
BILLING CODE 4160-01-F